ABSTRACT A hypothetical model was introduced to estimate the body burden of chelatable lead from the mobilisation yield of lead by calcium disodium ethylenediamine tetra-acetate (CaEDTA). It was estimated that, on average, 14 and 190/ of the body burden was mobilised into the urine during the 24 hours after an injection of 53-4 ,tmol (20 mg) and 107 Hmol (40 mg) CaEDTA per kg bodyweight, respectively. The body burden of chelatable lead ranged from 4 ,umol (0-8 mg) to 120 ,umol (24-9 mg) (mean 37 ,tmol (7 7 mg) ) in lead workers with blood lead concentrations of 0-3-2-9 ,umol!kg (6-60 ,tg/l00 g) (mean 1-4 ,umol/kg (29 ttg/l00 g) ). There were linear relationships between blood lead concentrations and body burden of chelatable lead on a log scale.
between blood lead concentrations and body burden of chelatable lead on a log scale.
In assessing the dose-response relationships of lead the dose may be estimated indirectly from the blood lead (BPb) and urinary lead concentrations, and the mobilisation yield of lead by calcium disodium ethylenediamine tetra-acetate (MPb).' There has been, however, no evidence that any of the indicators is correlated with lead concentrations in critical organs.2 The blood lead concentration is considered to be the most reliable indicator of recent exposure, and to be particularly useful for epidemiological studies.2 MPb, on the other hand, may serve as a "chemical biopsy" of the concentration of lead in critical organs,2 and be a sensitive indicator of excess lead absorption.3 The following evidence also suggests that there is some difference in the biological significance of BPb and MPb: (1) there is a curvilinear relationship between BPb and MPb4 5; (2) age does not correlate significantly with BPb in "healthy" adults under "normal" environmental conditions6 7 whereas MPb does8; and (3) The biological half time of non-chelatable lead should be very long since this form of lead is assumed to be firmly bound to the bone matrix.'0 Therefore, the daily conversion rate from nonchelatable lead to chelatable lead is almost negligible and so is the value of a. Hence equation (4) The values of k and A are calculated from equations (5) and (6) when MPb(1) and MPb(2) are measured.
Estimation of the body burden of chelatable lead in lead workers
The nature of the procedure was explained to all the subjects and this study was carried out with their informed consent. After measurements of BPb, CaEDTA was injected into eight male lead workers in a daily dosage of 53 4 ,tmol (20 mg) per kg bodyweight in 250 ml of 5 % glucose solution for one hour Araki and Ushio for two successive days (study 1). Urinary lead excretion was measured on both 24-hour urinary samples. The adequacy of urinary sampling was checked by measurements of urinary creatinine and specific gravity together with notification by the subjects. The subjects were free from occupational lead exposure during the period of the urinary collection. None had ever suffered from renal disease, and results of urine analysis for albumin was negative in all cases.
Blood and urinary lead concentrations were measured by atomic absorption spectrophotometry (Perkin-Elmer 403) after wet ashing, chelation by ammonium pyrrolidine dithiocarbamate and extraction to water-saturated methylisobutylketone. (2); the age and occupation of each subject are also shown in this table. It is estimated that about 14% of the body burden of chelatable lead is mobilised into the urine by the injection of 53 4 ,umol CaEDTA per kg bodyweight. This estimation is similar to that found in rabbits.'0 Further studies of the k value for other animal species would disclose whether the similarity is truly biological. Figure 1 shows a linear relationship between BPb and the body burden of chelatable lead on a log scale. The BPb of 2-9 ,umol/kg (60 pg/100 g) cor- responds to a body burden of 87 ,umol (18 mg) on the regression line; and the BPb of 05 ,umol/kg (10 ,ug/ 100 g), to a body burden of 6 ,mol (1-2 mg). These The validity of the first assumption may be tested by examining the correlations between the k and A lead are values. When tested under the null hypothesis using reported Spearman's rank correlation coefficient, the correlaead; 8166 tion is not significant in either of the two studies 404 ,umol (rs = 0 137 and 0-280 for studies 1 and 2, respectively p > 005). The first assumption, therefore, could not burden of be discarded. the body With regard to the second assumption, there is, so BPb de-far, no evidence against it. The half time of MPb has been diminution is extremely long in lead workers and in id MPb in rabbits after the termination of lead exposure. 9 10 workers.5 For instance, the half time of diminution was 103 when the and 174 weeks in two lead workers when 53 4 ,umol ol (40 mg) CaEDTA per kg bodyweight was injected once a e the first week for 3-5 years.9 Hence the diminution rate of examined MPb (and also chelatable lead) is assumed to be (study 1): 0 7 and 0.4% a week, respectively. In other words, was over the quantity of chelatable lead is reduced from A to ip between 0-993A or 0-996A during a week after a single ,d on a log injection of CaEDTA. On the other hand, after the 
